
Scott David Priebe
Examiner (ID: 14721)
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1633, 1819, 1805, 1632 |
| Total Applications | 686 |
| Issued Applications | 323 |
| Pending Applications | 150 |
| Abandoned Applications | 212 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6557948
[patent_doc_number] => 20020194634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Insect control system'
[patent_app_type] => new
[patent_app_number] => 10/068460
[patent_app_country] => US
[patent_app_date] => 2002-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7020
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20020194634.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068460 | Insect control system | Feb 5, 2002 | Abandoned |
Array
(
[id] => 982046
[patent_doc_number] => 06926889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-09
[patent_title] => 'Recombinant bacteria for use in insect control'
[patent_app_type] => utility
[patent_app_number] => 10/062821
[patent_app_country] => US
[patent_app_date] => 2002-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6983
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/926/06926889.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062821 | Recombinant bacteria for use in insect control | Jan 31, 2002 | Issued |
Array
(
[id] => 5843453
[patent_doc_number] => 20020131961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Method for gene transfer using Bcl2 and compositions useful therein'
[patent_app_type] => new
[patent_app_number] => 10/060762
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7652
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20020131961.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060762
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060762 | Method for gene transfer using Bcl2 and compositions useful therein | Jan 29, 2002 | Abandoned |
Array
(
[id] => 1167690
[patent_doc_number] => 06753146
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'System and method for evaluating agents which prevent oxidative damage'
[patent_app_type] => B1
[patent_app_number] => 09/913472
[patent_app_country] => US
[patent_app_date] => 2002-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2408
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753146.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913472
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913472 | System and method for evaluating agents which prevent oxidative damage | Jan 27, 2002 | Issued |
Array
(
[id] => 6763263
[patent_doc_number] => 20030126625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Screens and assays for agents useful in controlling parasitic nematodes'
[patent_app_type] => new
[patent_app_number] => 10/051644
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 35451
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20030126625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051644
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051644 | Screens and assays for agents useful in controlling parasitic nematodes | Jan 17, 2002 | Issued |
Array
(
[id] => 1136387
[patent_doc_number] => 06780411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-24
[patent_title] => 'Tissue sealant compositions'
[patent_app_type] => B2
[patent_app_number] => 10/053316
[patent_app_country] => US
[patent_app_date] => 2002-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 15908
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/780/06780411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10053316
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/053316 | Tissue sealant compositions | Jan 16, 2002 | Issued |
Array
(
[id] => 6113213
[patent_doc_number] => 20020173635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Secreted expressed sequence tags (sESTs)'
[patent_app_type] => new
[patent_app_number] => 10/040739
[patent_app_country] => US
[patent_app_date] => 2002-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41542
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6097
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20020173635.pdf
[firstpage_image] =>[orig_patent_app_number] => 10040739
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/040739 | Secreted expressed sequence tags (sESTs) | Jan 6, 2002 | Abandoned |
Array
(
[id] => 725290
[patent_doc_number] => 07045677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-16
[patent_title] => 'Fusion proteins incorporating lysozyme'
[patent_app_type] => utility
[patent_app_number] => 10/024597
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 10757
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/045/07045677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024597 | Fusion proteins incorporating lysozyme | Dec 20, 2001 | Issued |
Array
(
[id] => 776715
[patent_doc_number] => 06998118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-14
[patent_title] => 'Targeted retrograde gene delivery for neuronal protection'
[patent_app_type] => utility
[patent_app_number] => 10/032047
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8678
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/998/06998118.pdf
[firstpage_image] =>[orig_patent_app_number] => 10032047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/032047 | Targeted retrograde gene delivery for neuronal protection | Dec 20, 2001 | Issued |
Array
(
[id] => 6079877
[patent_doc_number] => 20020081297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Method of reducing an immune response to a recombinant virus'
[patent_app_type] => new
[patent_app_number] => 09/994965
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13920
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081297.pdf
[firstpage_image] =>[orig_patent_app_number] => 09994965
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/994965 | Method of reducing an immune response to a recombinant virus | Nov 26, 2001 | Abandoned |
Array
(
[id] => 5859163
[patent_doc_number] => 20020123147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Gene transfer with adenoviruses having modified fiber proteins'
[patent_app_type] => new
[patent_app_number] => 09/993502
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15831
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123147.pdf
[firstpage_image] =>[orig_patent_app_number] => 09993502
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/993502 | Gene transfer with adenoviruses having modified fiber proteins | Nov 26, 2001 | Abandoned |
Array
(
[id] => 6079877
[patent_doc_number] => 20020081297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Method of reducing an immune response to a recombinant virus'
[patent_app_type] => new
[patent_app_number] => 09/994965
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13920
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081297.pdf
[firstpage_image] =>[orig_patent_app_number] => 09994965
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/994965 | Method of reducing an immune response to a recombinant virus | Nov 26, 2001 | Abandoned |
Array
(
[id] => 5971864
[patent_doc_number] => 20020092033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Method and vector for expression and isolation of biologically active molecules in urine of transgenic animals'
[patent_app_type] => new
[patent_app_number] => 09/987844
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4934
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20020092033.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987844
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987844 | Method and vector for expression and isolation of biologically active molecules in urine of transgenic animals | Nov 15, 2001 | Abandoned |
| 09/857378 | Method for the immobilization of oligonucleotides | Nov 14, 2001 | Abandoned |
Array
(
[id] => 6427009
[patent_doc_number] => 20020184656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'In vivo assay system for screening and validation of drugs and other substances'
[patent_app_type] => new
[patent_app_number] => 09/987482
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12259
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20020184656.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987482
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987482 | In vivo assay system for screening and validation of drugs and other substances | Nov 13, 2001 | Abandoned |
Array
(
[id] => 5967321
[patent_doc_number] => 20020090363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Sustained bioactive agent delivery device and methods of making and using the same'
[patent_app_type] => new
[patent_app_number] => 10/008340
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3488
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090363.pdf
[firstpage_image] =>[orig_patent_app_number] => 10008340
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/008340 | Sustained bioactive agent delivery device and methods of making and using the same | Nov 12, 2001 | Abandoned |
Array
(
[id] => 6046834
[patent_doc_number] => 20020168342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods'
[patent_app_type] => new
[patent_app_number] => 10/036940
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15205
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168342.pdf
[firstpage_image] =>[orig_patent_app_number] => 10036940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/036940 | Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods | Nov 12, 2001 | Abandoned |
Array
(
[id] => 6241303
[patent_doc_number] => 20020044925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities'
[patent_app_type] => new
[patent_app_number] => 09/986344
[patent_app_country] => US
[patent_app_date] => 2001-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5397
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20020044925.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986344
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986344 | Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities | Nov 7, 2001 | Issued |
| 09/486660 | Transgenic animals for the study of biological, physical and chemical toxic agents | Oct 28, 2001 | Abandoned |
Array
(
[id] => 6468319
[patent_doc_number] => 20020151032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Packaging systems for human recombinant adenovirus to be used in gene therapy'
[patent_app_type] => new
[patent_app_number] => 10/038271
[patent_app_country] => US
[patent_app_date] => 2001-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 16435
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151032.pdf
[firstpage_image] =>[orig_patent_app_number] => 10038271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/038271 | Packaging systems for human recombinant adenovirus to be used in gene therapy | Oct 22, 2001 | Abandoned |